heart failure ("CHF") is a disease characterised by an inability of the heart to pump blood at a rate sufficient to support the needs of the body.
The inflammatory protein called tumor necrosis factor-alpha (TNF) may play a lead role in congestive
In some Gases, congestive
heart failure can be treated by controlling high blood pressure or surgically replacing abnormal heart valves.
A review of the Congestive
Heart Failure (Heart Failure) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
While the World Health Organization has reported a decreasing trend in cardiovascular disease for several decades, it reports an increase in the incidence of congestive
heart failure (CHF) which is often the end stage of cardiac disease.
Most studies probing the safety and usefulness of exercise in people with cancer or congestive
heart disease have yielded untrustworthy or inconclusive results.
10, 2015 /PRNewswire-iReach/ -- One major trend, witness in Global Congestive
Heart Failure (CHF) Drugs Market is the increase in awareness.
Overall, between 2 and 11 percent of hospital admissions for congestive
heart failure, depending on the city, could be traced to carbon monoxide.
The report provides an analysis of congestive
heart failure partnering deals.
To order this report: Pathology Industry : Congestive
Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2013
The new data confirm and extend earlier reports that angiotensin-converting-enzyme (ACE) inhibitors reduce the risk of early death for people with severe congestive
Top 5 Companies in Early Stage Congestive
Heart Failure Products